Page last updated: 2024-11-01

nifedipine and Niemann-Pick Diseases

nifedipine has been researched along with Niemann-Pick Diseases in 3 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Niemann-Pick Diseases: A group of autosomal recessive disorders in which harmful quantities of lipids accumulate in the viscera and the central nervous system. They can be caused by deficiencies of enzyme activities (SPHINGOMYELIN PHOSPHODIESTERASE) or defects in intracellular transport, resulting in the accumulation of SPHINGOMYELINS and CHOLESTEROL. There are various subtypes based on their clinical and genetic differences.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, T1
Tokoro, T1
Eto, Y1
Erickson, RP2
Garver, WS2
Camargo, F2
Hossain, GS2
Heidenreich, RA2
Carbone, PN1
Blanchard, J1

Other Studies

3 other studies available for nifedipine and Niemann-Pick Diseases

ArticleYear
The attenuated elevation of cytoplasmic calcium concentration following the uptake of low density lipoprotein in type C Niemann-Pick fibroblasts.
    Biochemical and biophysical research communications, 1994, Jan-28, Volume: 198, Issue:2

    Topics: Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cells, Cultured; Cholesterol, LDL; Cyto

1994
Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice.
    Journal of inherited metabolic disease, 2000, Volume: 23, Issue:1

    Topics: Animals; Blood-Brain Barrier; Cholesterol; Mice; Mice, Inbred BALB C; Mice, Knockout; Niemann-Pick D

2000
Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease.
    Life sciences, 2001, Nov-30, Volume: 70, Issue:2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anticholesteremic Agents; Ataxia; beta-Cyclodextrins; Bl

2001